{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
haloprogin
to a specific field?
There is one exact (name or code) match for haloprogin
Status:
US Approved OTC
Source:
21 CFR 333.210(b) antifungal haloprogin
Source URL:
First approved in 1971
Source:
HALOTEX by WESTWOOD SQUIBB
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Haloprogin is an active synthetic antifungal and antimonilial agent that was effective in the treatment of superficial fungal and monilial infections of the skin. Because of these two basic therapeutic effects, haloprogin was especially useful in the treatment of infections when the identity of the specific causative organism had not been established or is being determined. Studies in-vitro demonstrated antifungal, antimonilial and antibacterial activity. It was shown to demonstrate marked in-vitro activity against Staphylococcus and Streptococcus. Haloprogin is no longer available in the US.
Showing 1 - 1 of 1 results
Status:
US Approved OTC
Source:
21 CFR 333.210(b) antifungal haloprogin
Source URL:
First approved in 1971
Source:
HALOTEX by WESTWOOD SQUIBB
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Haloprogin is an active synthetic antifungal and antimonilial agent that was effective in the treatment of superficial fungal and monilial infections of the skin. Because of these two basic therapeutic effects, haloprogin was especially useful in the treatment of infections when the identity of the specific causative organism had not been established or is being determined. Studies in-vitro demonstrated antifungal, antimonilial and antibacterial activity. It was shown to demonstrate marked in-vitro activity against Staphylococcus and Streptococcus. Haloprogin is no longer available in the US.
